BioSpace News Archive

X4 Pharmaceuticals, Inc., a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, announced that, on September 30, 2020, the Compensation Committee of X4’s Board of Directors issued an inducement award to new employees under the X4 Pharmaceuticals, Inc.

Metacrine, Inc. (Nasdaq: MTCR), a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases, today announced that two posters highlighting new data on the company’s lead clinical candidate, MET409,

Sandoz Inc announced today that its first two injectable medicines with Radio Frequency Identification (RFID) tags will be available this month to US hospitals through its collaboration with Kit Check, Inc., a leader in automated medication management solutions for hospitals.

Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that it has completed the previously announced acquisition of Pharmaceutical Strategies Group’s (PSG) 340B Link business, pursuant to the terms and conditions of an Equity Purchase Agreement.

Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that Chen Schor, President and Chief Executive Officer of Adicet Bio, and Stewart Abbot, Ph.D., Chief Scientific and Operating Officer of Adicet Bio, will participate in a fireside chat at the Jefferies Cell Therapy Summit on Monday, October 5, 2020 at 2:30 PM ET.

The study examined what has been done and chartered a roadmap to improve equitable access using the best-available scientific literature on barriers to older adult participation in cancer clinical trials.

EasyCOV, a virological saliva detection test for COVID19, has shown a sensitivity of 88% and a specificity 99% during a clinical trial performed at the testing center operated by the teaching hospital of Montpellier.

The investment includes a fractionation plant with a 1.5 million-liter annual capacity and two purification plants, making Grifols the only large-scale commercial manufacturer of plasma products in Canada - This transaction highlights Grifols’ commitment to supporting countries such as Canada to attain self-sufficiency of essential plasma-derived medicines through

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the company’s participation at IO Combinations 360˚ which will be held online, October 1-2, 2020. The presentation, titled “Comprehensive immunogenomics to enable composite biomarkers for immunotherapy response using a sample sparing approach,” will describe the Perso

Packaging Technology Group (PTG) Completes Its Line of Thermally Pre-Qualified 2-8°C Shipping Solutions for Vaccines and Biologics BOSTON--( BUSINESS WIRE )-- Packaging Technology Group, Inc (PTG), a leading provider of thermal packaging solutions for the biopharmaceutical and life sciences sector, responds to the global pandemic with the launch of its off-the-shelf line of pre-qualified shippers, including an earth-friendly alternative. As pharmaceu